Skip to main content
Article
Association of regimens of hormone replacement therapy to prognostic factors among women diagnosed with breast cancer aged 50-64 years.
All Scholarly Works
  • Ronald Burkman, MD, Baystate Health
Document Type
Article, Peer-reviewed
Publication Date
11-1-2003
Abstract

This study was conducted to assess the histopathological features of breast cancers in women diagnosed with breast cancer at 50-64 years of age who have and have not used hormone replacement therapy (HRT). A case-case analysis of the tumors from women age

Publication ISSN
0010-7824
Citation Information
Cancer Epidemiol Biomarkers Prev 2003 Nov;12(11 Pt 1):1175-81. JIF= 4.720